Ulcerative colitis as a polymicrobial infection characterized by sustained broken mucus barrier

被引:75
作者
Chen, Shui-Jiao [1 ]
Liu, Xiao-Wei [1 ]
Liu, Jian-Ping [1 ]
Yang, Xi-Yan [1 ]
Lu, Fang-Gen [1 ]
机构
[1] Cent S Univ, Xiangya Hosp 2, Dept Gastroenterol, Changsha 410011, Hunan, Peoples R China
基金
中国国家自然科学基金;
关键词
Ulcerative colitis; Mucus; Infection; Bacteria; Etiology; INFLAMMATORY-BOWEL-DISEASE; BUTYRATE-PRODUCING BACTERIA; ESCHERICHIA-COLI; FECAL MICROBIOTA; INTESTINAL MICROBIOTA; COMMENSAL BACTERIA; PROBIOTIC BACTERIA; EPITHELIAL-CELLS; CLINICAL-ASPECTS; O-GLYCOSYLATION;
D O I
10.3748/wjg.v20.i28.9468
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
To reduce medication for patients with ulcerative colitis (UC), we need to establish the etiology of UC. The intestinal microbiota of patients with inflammatory bowel disease (IBD) has been shown to differ from that of healthy controls and abundant data indicate that it changes in both composition and localization. Small intestinal bacterial overgrowth is significantly higher in IBD patients compared with controls. Probiotics have been investigated for their capacity to reduce the severity of UC. The luminal surfaces of the gastrointestinal tract are covered by a mucus layer. This normally acts as a barrier that does not allow bacteria to reach the epithelial cells and thus limits the direct contact between the host and the bacteria. The mucus layer in the colon comprises an inner layer that is firmly adherent to the intestinal mucosa, and an outer layer that can be washed off with minimal rinsing. Some bacteria can dissolve the protective inner mucus layer. Defects in renewal and formation of the inner mucus layer allow bacteria to reach the epithelium and have implications for the causes of colitis. In this review, important elements of UC pathology are thought to be the intestinal bacteria, gut mucus, and the mucosa-associated immune system. (C) 2014 Baishideng Publishing Group Inc. All rights reserved.
引用
收藏
页码:9468 / 9475
页数:8
相关论文
共 99 条
[1]
Gastroenterology 2 - Inflammatory bowel disease: clinical aspects and established and evolving therapies [J].
Baumgart, Daniel C. ;
Sandborn, William J. .
LANCET, 2007, 369 (9573) :1641-1657
[2]
Muc2 Protects against Lethal Infectious Colitis by Disassociating Pathogenic and Commensal Bacteria from the Colonic Mucosa [J].
Bergstrom, Kirk S. B. ;
Kissoon-Singh, Vanessa ;
Gibson, Deanna L. ;
Ma, Caixia ;
Montero, Marinieve ;
Sham, Ho Pan ;
Ryz, Natasha ;
Huang, Tina ;
Velcich, Anna ;
Finlay, B. Brett ;
Chadee, Kris ;
Vallance, Bruce A. .
PLOS PATHOGENS, 2010, 6 (05)
[3]
VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis [J].
Bibiloni, R ;
Fedorak, RN ;
Tannock, GW ;
Madsen, KL ;
Gionchetti, P ;
Campieri, M ;
De Simone, C ;
Sartor, RB .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (07) :1539-1546
[4]
Identification of enterohepatic Helicobacter species in patients suffering from inflammatory bowel disease [J].
Bohr, URM ;
Glasbrenner, B ;
Primus, A ;
Zagoura, A ;
Wex, T ;
Malfertheiner, P .
JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (06) :2766-2768
[5]
Bullock Natalie R, 2004, Curr Issues Intest Microbiol, V5, P59
[6]
The regulation of intestinal mucin MUC2 expression by short-chain fatty acids: implications for epithelial protection [J].
Burger-van Paassen, Nanda ;
Vincent, Audrey ;
Puiman, Patrycja J. ;
van der Sluis, Maria ;
Bouma, Janneke ;
Boehm, Gunther ;
van Goudoever, Johannes B. ;
Van Seuningen, Isabelle ;
Renes, Ingrid B. .
BIOCHEMICAL JOURNAL, 2009, 420 :211-219
[7]
Role of commercial probiotic strains against human pathogen adhesion to intestinal mucus [J].
Collado, M. C. ;
Meriluoto, J. ;
Salminen, S. .
LETTERS IN APPLIED MICROBIOLOGY, 2007, 45 (04) :454-460
[8]
Intestinal integrity and Akkermansia muciniphila, a mucin-degrading member of the intestinal microbiota present in infants, adults, and the elderly [J].
Collado, M. Carmen ;
Derrien, Muriel ;
Isolauri, Erika .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2007, 73 (23) :7767-7770
[9]
Mesalazine for the treatment of inflammatory bowel disease [J].
Criscuoli, Valeria ;
Modesto, Irene ;
Orlando, Ambrogio ;
Cottone, Mario .
EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (12) :1669-1678
[10]
Rectal Administration of Lactobacillus casei DG Modifies Flora Composition and Toll-Like Receptor Expression in Colonic Mucosa of Patients with Mild Ulcerative Colitis [J].
D'Inca, Renata ;
Barollo, Michela ;
Scarpa, Marco ;
Grillo, Alessia Rosaria ;
Brun, Paola ;
Vettorato, Maria Grazia ;
Castagliuolo, Ignazio ;
Sturniolo, Giacomo Carlo .
DIGESTIVE DISEASES AND SCIENCES, 2011, 56 (04) :1178-1187